Standout Papers
- Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer (2010)
- Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study (2017)
- Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial (2017)
Immediate Impact
6 by Nobel laureates 3 from Science/Nature 67 standout
Citing Papers
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer
2022 Standout
Brain Co‐Delivery of Temozolomide and Cisplatin for Combinatorial Glioblastoma Chemotherapy
2022 Standout
Works of Luc Dirix being referenced
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
2017 Standout
Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
2001
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Luc Dirix | 9210 | 4490 | 3359 | 4363 | 305 | 14.2k | |
| Suzette Delaloge | 8220 | 4873 | 3665 | 3290 | 395 | 13.5k | |
| Angelo Di Leo | 9688 | 5062 | 4372 | 4024 | 309 | 14.0k | |
| Sabino De Placido | 7699 | 3698 | 4412 | 4332 | 376 | 13.7k | |
| P. Fumoleau | 9431 | 4272 | 2609 | 3207 | 324 | 14.0k | |
| Alberto Ocaña | 7114 | 2453 | 2462 | 3696 | 296 | 12.0k | |
| Patrice Viens | 10328 | 5512 | 2790 | 5886 | 352 | 17.1k | |
| Ahmad Awada | 9304 | 2904 | 4663 | 5051 | 538 | 15.7k | |
| Young‐Hyuck Im | 8436 | 3677 | 3586 | 2824 | 265 | 11.9k | |
| Stefan Sleijfer | 6993 | 3472 | 4582 | 4150 | 378 | 13.2k | |
| Joseph A. Sparano | 10208 | 5169 | 2633 | 3678 | 390 | 15.5k |
All Works
Loading papers...